Related references
Note: Only part of the references are listed.Prospects for Prophylactic and Therapeutic Vaccines Against Hepatitis C Virus
Stephen M. Feinstone et al.
CLINICAL INFECTIOUS DISEASES (2012)
Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities
Farzin Roohvand et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Complete Definition of Immunological Correlates of Protection and Clearance of Hepatitis C Virus Infection: A Relevant Pending Task for Vaccine Development
Liz Alvarez-Lajonchere et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2012)
Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence
Julian Schulze zur Wiesch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Antiviral strategies in hepatitis C virus infection
Christoph Sarrazin et al.
JOURNAL OF HEPATOLOGY (2012)
Spontaneous Clearance of Chronic Hepatitis C Virus Infection Is Associated With Appearance of Neutralizing Antibodies and Reversal of T-Cell Exhaustion
Sukanya Raghuraman et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
Erick Giang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
Eleanor Barnes et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Evolving epidemiology of hepatitis C virus
D. Lavanchy
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Advances in hepatitis C virus vaccines, part one: advances in basic knowledge for hepatitis C virus vaccine design
Farzin Roohvand et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
Michael Houghton
IMMUNOLOGICAL REVIEWS (2011)
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
Joseph Torresi et al.
JOURNAL OF HEPATOLOGY (2011)
Vaccine-Induced Cross-Genotype Reactive Neutralizing Antibodies Against Hepatitis C Virus
Jean-Christophe Meunier et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Hepatitis B Virus Surface Antigen Assembly Function Persists when Entire Transmembrane Domains 1 and 3 Are Replaced by a Heterologous Transmembrane Sequence
Ira Berkower et al.
JOURNAL OF VIROLOGY (2011)
Test and treat this silent killer
Brian R. Edlin
NATURE (2011)
A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques
Pierre Garrone et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Construction and Immunological Evaluation of Multivalent Hepatitis B Virus (HBV) Core Virus-Like Particles Carrying HBV and HCV Epitopes
Irina Sominskaya et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Meta-Analysis of Hepatitis C Virus Vaccine Efficacy in Chimpanzees Indicates an Importance for Structural Proteins
Harel Dahari et al.
GASTROENTEROLOGY (2010)
Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection
William O. Osburn et al.
GASTROENTEROLOGY (2010)
Selection-Driven Immune Escape Is Not a Significant Factor in the Failure of CD4 T Cell Responses in Persistent Hepatitis C Virus Infection
Michael J. Fuller et al.
HEPATOLOGY (2010)
Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope Glycoproteins
Ranjit Ray et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Acceleration of Hepatitis C Virus Envelope Evolution in Humans Is Consistent with Progressive Humoral Immune Selection during the Transition from Acute to Chronic Infection
Lin Liu et al.
JOURNAL OF VIROLOGY (2010)
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
Sharon E. Frey et al.
VACCINE (2010)
Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C Virus
Kimberly A. Dowd et al.
GASTROENTEROLOGY (2009)
Development and Characterization of Hepatitis C Virus Genotype 1-7 Cell Culture Systems: Role of CD81 and Scavenger Receptor Class B Type I and Effect of Antiviral Drugs
Judith M. Gottwein et al.
HEPATOLOGY (2009)
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial
Nubia Munoz et al.
LANCET (2009)
Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies
Romuald Patient et al.
NEW BIOTECHNOLOGY (2009)
Hepatitis C vaccine: supply and demand
G. Thomas Strickland et al.
LANCET INFECTIOUS DISEASES (2008)
Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles
S. Phogat et al.
VIROLOGY (2008)
Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge
Mansun Law et al.
NATURE MEDICINE (2008)
Isolation and characterization of broadly neutralizing human monoclonal antibodies to the E1 glycoprotein of hepatitis C virus
Jean-Christophe Meunier et al.
JOURNAL OF VIROLOGY (2008)
Virus-like particles - universal molecular toolboxes
Christine Ludwig et al.
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Tracking Virus-Specific CD4+T Cells during and after Acute Hepatitis C Virus Infection
Michaela Lucas et al.
PLOS ONE (2007)
Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: Evidence for the critical function of multimerization
Jerome Denis et al.
VIROLOGY (2007)
Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees
Gamal A. Elmowalid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
Jan M. Pestka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus
Montserrat Puig et al.
HEPATOLOGY (2006)
Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV)
Marija Mihailova et al.
VACCINE (2006)
Signal sequences modulate the immunogenic performance of human hepatitis C virus E2 gene
Irina Sominskaya et al.
MOLECULAR IMMUNOLOGY (2006)
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
A Folgori et al.
NATURE MEDICINE (2006)
Treating viral hepatitis C: Efficacy, side effects, and complications
M. P. Manns et al.
GUT (2006)
Epidemiology of viral hepatitis and HIV co-infection
MJ Alter
JOURNAL OF HEPATOLOGY (2006)
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
P Simmonds et al.
HEPATOLOGY (2005)
Prospects for a vaccine against the hepatitis C virus
M Houghton et al.
NATURE (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
T Wakita et al.
NATURE MEDICINE (2005)
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection
D Lavillette et al.
JOURNAL OF VIROLOGY (2005)
Immunogenicity and Tolerability of Intradermal Administration of an HCV E1-Based Vaccine Candidate in Healthy Volunteers and Patients with Resolved or Ongoing Chronic HCV Infection
Geert Leroux-Roels et al.
HUMAN VACCINES (2005)
Cross-genotype immunity to hepatitis C virus
RE Lanford et al.
JOURNAL OF VIROLOGY (2004)
Neutralizing antibody response during acute and chronic hepatitis C virus infection
C Logvinoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Human monoclonal antibody to hepatitis C virus El glycoprotein that blocks virus attachment and viral infectivity
ZY Keck et al.
JOURNAL OF VIROLOGY (2004)
Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates
SH Jeong et al.
JOURNAL OF VIROLOGY (2004)
In vitro assay for neutralizing antibody to hepatitis C virus:: Evidence for broadly conserved neutralization epitopes
B Bartosch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection
NH Shoukry et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection
K Murata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes
B Bartosch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding
M Triyatni et al.
VIROLOGY (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice
M Lechmann et al.
HEPATOLOGY (2001)
Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes
HJ Netter et al.
JOURNAL OF VIROLOGY (2001)